Stay updated on Pralsetinib vs Standard of Care in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Pralsetinib vs Standard of Care in NSCLC Clinical Trial page.

Latest updates to the Pralsetinib vs Standard of Care in NSCLC Clinical Trial page
- Check5 days agoChange DetectedThe page now states that the trial was terminated globally (excluding US and Greater China) with results posted, and it adds details showing 74 study locations.SummaryDifference2%

- Check12 days agoNo Change Detected
- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision: v3.4.2 has been added; the notices about a lapse in government funding and Revision: v3.4.1 have been removed. These are minor site maintenance changes and do not affect study content; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check41 days agoChange DetectedA global site notice about government funding and NIH operations was added, and the page revision was updated from v3.4.0 to v3.4.1.SummaryDifference0.2%

- Check48 days agoChange DetectedUI/metadata updates: glossary toggle added, a new 'Last Update Submitted that Met QC Criteria' label, and a revision indicator (v3.4.0); the prior lowercase QC label ('Last Update Submitted that met QC Criteria'), 'No FEAR Act data' wording, and older revision text (v3.3.4) were removed.SummaryDifference0.1%

- Check62 days agoChange DetectedThe page footer now shows Revision: v3.3.4, replacing Revision: v3.3.3.SummaryDifference0.0%

- Check69 days agoChange DetectedThe page now displays 'Results Submitted' instead of 'No Results Posted'. This indicates that study results have been submitted for the record.SummaryDifference0.0%

Stay in the know with updates to Pralsetinib vs Standard of Care in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pralsetinib vs Standard of Care in NSCLC Clinical Trial page.